Trial intelligence / Profile preview

Phase II crossover study of V0147 (alprostadil) gel in spinal cord injured patients with erectile dysfunction

2007-001058-16Phase 2Terminated

Sponsor
Pierre Fabre Laboratories
Start
Mar 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Vasostenoon in erectile dysfunction (ED), sponsored by Pierre Fabre Laboratories. Started Mar 2007; status: terminated.

02

Drugs

Vasostenoon
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on 2007-001058-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-001058-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call